AP:

For all of her 20s, when Edjuana Ross should have been relishing the thrill of early adulthood, she was instead in and out of hospitals, battling a disease that attacked her skin, brain and heart.
Now, at 33, she has her life back, thanks to a stem-cell transplant from her own bone marrow, a drastic, experimental treatment that could be promising for patients with severe lupus.
Ross’ illness is in remission for the first time since her diagnosis shortly after high school graduation.
“I’m just trying to get used to being well, and it’s a very weird feeling,” Ross said.
The Park Forest, Ill., woman is among 48 patients with severe lupus who had the treatment at Northwestern Memorial Hospital. Thirty-three patients have had no disease symptoms for up to more than seven years following their transplants, said Northwestern’s Dr. Richard Burt, who led the study.
Six patients died from causes unrelated to the treatment.
The probability of disease-free survival for five years was 50 percent, encouraging for those who failed more conventional treatment for the most severe form of lupus, a disease in which the body’s immune system attacks its own organs and tissues.
“It turned out very well, showing that we could do this safely,” Burt said.
The study appears in Wednesday’s Journal of the American Medical Association. It expands on short-term results with fewer patients the same researchers reported in 2000.